Literature DB >> 16507988

Inflammatory disease and lymphomagenesis caused by deletion of the Myc antagonist Mnt in T cells.

Shala Dezfouli1, Antony Bakke, Jie Huang, Anthony Wynshaw-Boris, Peter J Hurlin.   

Abstract

Mnt is a Max-interacting protein that can antagonize the activities of Myc oncoproteins in cultured cells. Mnt null mice die soon after birth, but conditional deletion of Mnt in breast epithelium leads to tumor formation. These and related data suggest that Mnt functions as a tumor suppressor. Here we show that conditional deletion of Mnt in T cells leads to tumor formation but also causes inflammatory disease. Deletion of Mnt caused increased apoptosis of thymic T cells and interfered with T-cell development yet led to spleen, liver, and lymph node enlargement. The proportion of T cells in the spleen and lymph nodes was reduced, and the numbers of cells in non-T-cell immune cell populations were elevated. The disruption of immune homeostasis is linked to a strong skewing toward production of T-helper 1 (Th1) cytokines and enhanced proliferation of activated Mnt-deficient CD4+ T cells. Consistent with Th1 polarization in vivo, extensive intestinal inflammation and liver necrosis developed. Finally, most mice lacking Mnt in T cells ultimately succumbed to T-cell lymphoma. These results strengthen the argument that Mnt functions as a tumor suppressor and reveal a critical and surprising role for Mnt in the regulation of T-cell development and in T-cell-dependent immune homeostasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16507988      PMCID: PMC1430277          DOI: 10.1128/MCB.26.6.2080-2092.2006

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  56 in total

1.  Reversible activation of c-Myc in thymocytes enhances positive selection and induces proliferation and apoptosis in vitro.

Authors:  B Rudolph; A O Hueber; G I Evan
Journal:  Oncogene       Date:  2000-04-06       Impact factor: 9.867

2.  The Myc trilogy: lord of RNA polymerases.

Authors:  Thordur Oskarsson; Andreas Trumpp
Journal:  Nat Cell Biol       Date:  2005-03       Impact factor: 28.824

Review 3.  Transcriptional regulation and transformation by Myc proteins.

Authors:  Sovana Adhikary; Martin Eilers
Journal:  Nat Rev Mol Cell Biol       Date:  2005-08       Impact factor: 94.444

4.  Targeted deletion of the S-phase-specific Myc antagonist Mad3 sensitizes neuronal and lymphoid cells to radiation-induced apoptosis.

Authors:  C Quéva; G A McArthur; B M Iritani; R N Eisenman
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

5.  Fas-independent apoptosis in T-cell tumours induced by the CD2-myc transgene.

Authors:  E R Cameron; J Morton; C J Johnston; J Irvine; M Bell; D E Onions; J C Neil; M Campbell; K Blyth
Journal:  Cell Death Differ       Date:  2000-01       Impact factor: 15.828

6.  T-cell lymphomas mask slower developing B-lymphoid and myeloid tumours in transgenic mice with broad haemopoietic expression of MYC.

Authors:  Darrin P Smith; Mary L Bath; Alan W Harris; Suzanne Cory
Journal:  Oncogene       Date:  2005-05-19       Impact factor: 9.867

7.  The transcriptional repressor dMnt is a regulator of growth in Drosophila melanogaster.

Authors:  Lenora W M Loo; Julie Secombe; John T Little; Leni-Sue Carlos; Cynthia Yost; Pei-Feng Cheng; Erin M Flynn; Bruce A Edgar; Robert N Eisenman
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

Review 8.  The role of the T cell in autoimmune inflammation.

Authors:  Alla Skapenko; Jan Leipe; Peter E Lipsky; Hendrik Schulze-Koops
Journal:  Arthritis Res Ther       Date:  2005-03-16       Impact factor: 5.156

9.  Mnt-Max to Myc-Max complex switching regulates cell cycle entry.

Authors:  William Walker; Zi-Qiang Zhou; Sara Ota; Anthony Wynshaw-Boris; Peter J Hurlin
Journal:  J Cell Biol       Date:  2005-05-02       Impact factor: 10.539

Review 10.  Cell fate decision: T-helper 1 and 2 subsets in immune responses.

Authors:  C Dong; R A Flavell
Journal:  Arthritis Res       Date:  2000-03-27
View more
  15 in total

Review 1.  An overview of MYC and its interactome.

Authors:  Maralice Conacci-Sorrell; Lisa McFerrin; Robert N Eisenman
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

Review 2.  Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis.

Authors:  Daniel Diolaiti; Lisa McFerrin; Patrick A Carroll; Robert N Eisenman
Journal:  Biochim Biophys Acta       Date:  2014-05-22

3.  Conditional deletion of N-Myc disrupts neurosensory and non-sensory development of the ear.

Authors:  Benjamin Kopecky; Peter Santi; Shane Johnson; Heather Schmitz; Bernd Fritzsch
Journal:  Dev Dyn       Date:  2011-03-29       Impact factor: 3.780

4.  Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas.

Authors:  Franz X Schaub; Varsha Dhankani; Ashton C Berger; Mihir Trivedi; Anne B Richardson; Reid Shaw; Wei Zhao; Xiaoyang Zhang; Andrea Ventura; Yuexin Liu; Donald E Ayer; Peter J Hurlin; Andrew D Cherniack; Robert N Eisenman; Brady Bernard; Carla Grandori
Journal:  Cell Syst       Date:  2018-03-28       Impact factor: 10.304

5.  The MNT transcription factor autoregulates its expression and supports proliferation in MYC-associated factor X (MAX)-deficient cells.

Authors:  M Carmen Lafita-Navarro; Judit Liaño-Pons; Andrea Quintanilla; Ignacio Varela; Rosa Blanco; Fabiana Ourique; Gabriel Bretones; Julia Aresti; Ester Molina; Patrick Carroll; Peter Hurlin; Octavio A Romero; Montse Sanchez-Céspedes; Robert N Eisenman; M Dolores Delgado; Javier León
Journal:  J Biol Chem       Date:  2020-01-09       Impact factor: 5.157

6.  OX40 engagement stabilizes Mxd4 and Mnt protein levels in antigen-stimulated T cells leading to an increase in cell survival.

Authors:  Nicole A Vasilevsky; Carl E Ruby; Peter J Hurlin; Andrew D Weinberg
Journal:  Eur J Immunol       Date:  2011-03-14       Impact factor: 5.532

Review 7.  Normal and Neoplastic Growth Suppression by the Extended Myc Network.

Authors:  Edward V Prochownik; Huabo Wang
Journal:  Cells       Date:  2022-02-21       Impact factor: 6.600

8.  MYC needs MNT.

Authors:  Jason M Link; Peter J Hurlin
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

9.  A critical role for Mnt in Myc-driven T-cell proliferation and oncogenesis.

Authors:  Jason M Link; Sara Ota; Zi-Qiang Zhou; Colin J Daniel; Rosalie C Sears; Peter J Hurlin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-12       Impact factor: 11.205

10.  Development and survival of MYC-driven lymphomas require the MYC antagonist MNT to curb MYC-induced apoptosis.

Authors:  Hai Vu Nguyen; Cassandra J Vandenberg; Ashley P Ng; Mikara R Robati; Natasha S Anstee; Joel Rimes; Edwin D Hawkins; Suzanne Cory
Journal:  Blood       Date:  2020-03-26       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.